Abnormal gait in a child with fever: Diagnosing septic arthritis of the hip

Pediatric Emergency Care

Volumn 21, Issue 5, 2005, Pages 336-341

  Shah, Samir S ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Child; Diagnostic evaluation; Hip pain; Infectious arthritis

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; LINEZOLID; OXACILLIN; OXAZOLIDINONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL ARTHRITIS; BONE MARROW SUPPRESSION; BONE PAIN; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; GAIT DISORDER; HIP DISEASE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; REVIEW; SYNOVITIS;

ARTHRITIS, INFECTIOUS; CHILD, PRESCHOOL; DECISION TREES; FEMALE; FEVER; GAIT; HIP JOINT; HUMANS;

EID: 19944383138     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000159063.24820.73     Document Type: Review

References (39)

1. Shah SS, Owusu-Antwi J, Zaoutis LB. Back, joint, and extremity pain. In: Shah SS, Ludwig S, eds. Pediatric Complaints and Diagnostic Dilemmas: A Case-Based Approach. Philadelphia: Lippincott Williams and Wilkins; 2004:117-151.
2. Nelson JD. Skeletal infections in children. Adv Pediatr Infect Dis. 1991;6:59-78.
3. Howard JB, Highgenboten CL, Nelson JD. Residual effects of septic arthritis in infancy and childhood. JAMA. 1976;236:932-935.
4. Welkon CJ, Long SS, Fisher MC, et al. Pyogenic arthritis in infants and children: a review of 95 cases. Pediatr Infect Dis. 1986;5:669-676.
5. Kallio MJT, Unkila-Kallio L, Aalto K, et al. Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J. 1997;16:411-413.
6. Levine MJ, McGuire KJ, McGowan KL, et al. Assessment of the test characteristics of c-reactive protein for septic arthritis in children. J Pediatr Orthop. 2003;23:373-377.
7. Jung ST, Row SM, Moon ES, et al. Significance of laboratory and radiologic findings for differentiating between septic arthritis and transient synovitis of the hip. J Pediatr Orthop. 2003;23:368-372.
8. Kocher MS, Zurakowski D, Kasser JR. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg. 1999;81-A:1662-1670.
9. Taylor GR, Clarke NM. Management of irritable hip: a review of hospital admission policy. Arch Dis Child. 1994;71:59-63.
10. Del Beccaro MA, Champoux AN, Bockers T, et al. Septic arthritis versus transient synovitis of the hip: value of screening laboratory tests. Ann Emerg Med. 1992;21:1418-1422.
11. Ehrendorfer S, LeQuesne G, Penta M, et al. Bilateral synovitis in symptomatic unilateral transient synovitis of the hip: an ultrasonographic study in 56 children. Acta Orthop Scand. 1996;67:149-152.
12. Lee SK, Suh KJ, Kim YW, et al. Septic arthritis versus transient synovitis at MR imaging: preliminary assessment with signal intensity alterations in bone marrow. Radiology. 1999;211:459-465.
13. Erdman WA, Tamburro F, Jayson HT, et al. Osteomyelitis: characteristics and pitfalls of diagnosis with MR imaging. Radiology. 1991;180:533-539.
14. Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med. 1985;312:764-771.
15. Yagupsky P, Bar-Ziv Y, Howard CB, et al. Epidemiology, etiology, and clinical features of septic arthritis in children younger than 24 months. Arch Pediatr Adolesc Med. 1995;149:537-540.
16. Moffett KS, Aronoff SC. Infectious arthritis. In: Jenson HB, Baltimore RS, eds. Pediatric Infectious Diseases: Principles and Practice. 2nd ed. Philadelphia: WB Saunders; 2002:1044-1050.
17. Lyon RM, Evanich JD. Culture-negative septic arthritis in children. J Pediatr Orthop. 1999;19:655-659.
18. Centers for Disease Control and Prevention. Osteomyelitis/septic arthritis caused by Kingella kingae among day care attendees - Minnesota, 2003. MMWR. 2004;53:241-243.
19. Yagupsky P, Dagan R, Howard CB, et al. High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system. J Clin Microbiol. 1992;30:1278-1281.
20. Bradley JS, Kaplan SL, Tan TQ, et al. Pediatric pneumococcal bone and joint infections. Pediatrics. 1998;102:1376-1382.
21. Gerber MA, Zemel LS, Shapiro ED. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics. 1998;102:905-908.
22. Hussain FM, Boyle-Vavra S, Bethel CD, et al. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J. 2000;19:1163-1166.
23. Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics. 2004;113:e347-e352.
24. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis. 2001;33:990-996.
25. Frank AL, Marcinak JF, Mangat PD, et al. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J. 1999;18:993-1000.
26. Martinez-Aguilar G, Hammerman WA, Mason EO Jr, et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003;22:593-598.
27. Feigin RD, Pickering LK, Anderson D, et al. Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatrics. 1975;55:213-223.
28. Leclerq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother. 1991;35:1267-1272.
29. Panagea S, Perry J, Gould F. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother. 1999;44:581-582.
30. Siberry G, Tekle T, Carroll K, et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003;37:1257-1260.
31. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR. 2002;51:565-567.
32. Sattar MA, Cawley MI, Hold JE, et al. The penetration of trimethoprim and sulphamethoxazole into synovial fluid. J Antimicrob Chemother. 1983;12:229-233.
33. Champney WS, Miller M. Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells. Curr Microbiol. 2002;44:350-356.
34. Gerson SL, Kaplan SL, Bruss JB, et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother. 2002;46:2723-2726.
35. Rao N, Ziran BH, Wagener MM, et al. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. Clin Infect Dis. 2004;38:1058-1064.
36. Khachatourians AG, Patzakis MJ, Roidis N, et al. Laboratory monitoring in pediatric acute osteomyelitis and septic arthritis. Clin Orthop. 2003;409:186-194.
37. Kim HKW, Alman B, Cole WG. A shortened course of parenteral antibiotic therapy in management of acute septic arthritis of the hip. J Pediatr Orthop. 2000;20:44-47.
38. Newton PO, Ballock RT, Bradley JS. Oral antibiotic therapy of bacterial arthritis. Pediatr Infect Dis J. 1999;18:1102-1103.
39. Dagan R. Management of acute hematogenous osetomyelitis and septic arthritis in the pediatric patient. Pediatr Infect Dis J. 1993;12:88-93.